Liver/Biliary Disorders

Top Story

Healio to report live from DDW 2019

  <i>Healio </i>to report live from DDW 2019
May 17, 2019

Dicerna doses first patient in trial of RNA inhibitor for chronic HBV

May 17, 2019
Dicerna dosed the first patient in a phase 1 clinical trial for DCR-HBVS, an investigational GalXCTM-based therapy for the treatment of chronic hepatitis B, according to…
In the Journals

Daily aspirin use reduces risk for fibrosis progression in NAFLD

May 16, 2019
Results from a prospective study of patients with biopsy-proven nonalcoholic fatty liver disease showed that daily aspirin use correlated with less severe histologic…

Mallinckrodt completes phase 3 enrollment for hepatorenal syndrome drug

May 15, 2019
Mallinckrodt achieved target enrollment of 300 participants for a phase 3 clinical study designed to evaluate the safety and efficacy of terlipressin for patients with…
More Headlines »

Best of IBD Forum 2018

This activity is supported by educational grants from AbbVie, Inc.; Pfizer, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: First step to HBV cure is ‘understanding the virus’

April 26, 2019
More »